U.S. FDA approves RedHill's H. pylori infection treatment
U.S. FDA approves RedHill's H. pylori infection treatment
Reuters: Health
The U.S. Food and Drug Administration has approved RedHill Biopharma Ltd's drug to treat infections caused by bacteria known as Helicobacter pylori, the Israel-based company said on Monday.
No comments:
Post a Comment